Identification Generic Name (2R)-2-{[4-(benzylamino)-8-(1-methylethyl)pyrazolo[1,5-a][1,3,5]triazin-2-yl]amino}butan-1-ol DrugBank Accession Number DB08285 Background Not Available Type Small Molecule Groups Experimental Structure 
 
 
 3D Download  MOL SDF 3D-SDF PDB SMILES InChI 
 
 
  Similar Structures Structure for (2R)-2-{[4-(benzylamino)-8-(1-methylethyl)pyrazolo[1,5-a][1,3,5]triazin-2-yl]amino}butan-1-ol (DB08285) ×  Close Weight Average: 354.4493  Monoisotopic: 354.216809484  Chemical Formula C 19 H 26 N 6 O Synonyms Not Available Pharmacology Indication Not Available Reduce drug development failure rates Build, train, & validate machine-learning models with evidence-based and structured datasets. See how     Build, train, & validate predictive machine-learning models with structured datasets. See how Contraindications & Blackbox Warnings Avoid life-threatening adverse drug events Improve clinical decision support with information on  contraindications & blackbox warnings, population restrictions, harmful risks, & more. Learn more     Avoid life-threatening adverse drug events & improve clinical decision support. Learn more Pharmacodynamics Not Available Mechanism of action Target Actions Organism U Cyclin-dependent kinase 2 Not Available Humans U Cyclin-A2 Not Available Humans Absorption Not Available Volume of distribution Not Available Protein binding Not Available Metabolism Not Available Route of elimination Not Available Half-life Not Available Clearance Not Available Adverse Effects Improve decision support & research outcomes With structured adverse effects data, including:  blackbox warnings, adverse reactions, warning & precautions, & incidence rates. Learn more     Improve decision support & research outcomes with our structured adverse effects data. Learn more Toxicity Not Available Pathways Not Available Pharmacogenomic Effects/ADRs  
 
 
 Not Available Interactions Drug Interactions  
 
 
 This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.  Not Available Food Interactions Not Available Categories Drug Categories Not Available Chemical Taxonomy Provided by  Classyfire Description This compound belongs to the class of organic compounds known as 2-benzylamino-s-triazines. These are aromatic heterocyclic compounds containing a S-triazine ring, which is N-substituted at the 2-position with a benzylamine. Kingdom Organic compounds Super Class Organoheterocyclic compounds Class Triazines Sub Class Aminotriazines Direct Parent 2-benzylamino-s-triazines Alternative Parents Pyrazolotriazines  /  Pyrazolo[1,5-a][1,3,5]triazines  /  Benzylamines  /  1,3,5-triazine-2,4-diamines  /  Secondary alkylarylamines  /  1,3,5-triazines  /  Pyrazoles  /  Heteroaromatic compounds  /  Azacyclic compounds  /  Primary alcohols  /  Organopnictogen compounds  /  Hydrocarbon derivatives 
 
 
  show 2 more Substituents 1,3,5-triazine  /  2,4-diamine-s-triazine  /  2-benzylamino-s-triazine  /  Alcohol  /  Amine  /  Aromatic heteropolycyclic compound  /  Azacycle  /  Azole  /  Benzenoid  /  Benzylamine  /  Heteroaromatic compound  /  Hydrocarbon derivative  /  Monocyclic benzene moiety  /  Organic nitrogen compound  /  Organic oxygen compound  /  Organonitrogen compound  /  Organooxygen compound  /  Organopnictogen compound  /  Primary alcohol  /  Pyrazole  /  Pyrazolo[1,5-a][1,3,5]triazine  /  Pyrazolotriazine  /  Secondary aliphatic/aromatic amine  /  Secondary amine 
 
 
  show 14 more Molecular Framework Aromatic heteropolycyclic compounds External Descriptors Not Available Affected organisms Not Available Chemical Identifiers UNII Not Available CAS number Not Available InChI Key SQUNOCMDMIQIQK-OAHLLOKOSA-N InChI InChI=1S/C19H26N6O/c1-4-15(12-26)22-18-23-17-16(13(2)3)11-21-25(17)19(24-18)20-10-14-8-6-5-7-9-14/h5-9,11,13,15,26H,4,10,12H2,1-3H3,(H2,20,22,23,24)/t15-/m1/s1 IUPAC Name (2R)-2-{[4-(benzylamino)-8-(propan-2-yl)pyrazolo[1,5-a][1,3,5]triazin-2-yl]amino}butan-1-ol SMILES [H][C@@](CC)(CO)NC1=NC2=C(C=NN2C(NCC2=CC=CC=C2)=N1)C(C)C References General References Not Available External Links PubChem Compound 25190761 PubChem Substance 99444756 ChemSpider 24700216 BindingDB 27217 ChEMBL CHEMBL482193 PDBe Ligand NNN PDB Entries 3dog Clinical Trials Clinical Trials  
 
 
 Phase Status Purpose Conditions Count Pharmacoeconomics Manufacturers Not Available Packagers Not Available Dosage Forms Not Available Prices Not Available Patents Not Available Properties State Solid Experimental Properties Not Available Predicted Properties Property Value Source Water Solubility 0.0132 mg/mL ALOGPS logP 3.21 ALOGPS logP 3.49 Chemaxon logS -4.4 ALOGPS pKa (Strongest Acidic) 13.32 Chemaxon pKa (Strongest Basic) 2.77 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 6 Chemaxon Hydrogen Donor Count 3 Chemaxon Polar Surface Area 87.37 Å 2 Chemaxon Rotatable Bond Count 8 Chemaxon Refractivity 116.79 m 3 ·mol -1 Chemaxon Polarizability 40.38 Å 3 Chemaxon Number of Rings 3 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule Yes Chemaxon Predicted ADMET Features Property Value Probability Human Intestinal Absorption + 1.0 Blood Brain Barrier + 0.5268 Caco-2 permeable - 0.5874 P-glycoprotein substrate Substrate 0.7894 P-glycoprotein inhibitor I Non-inhibitor 0.7647 P-glycoprotein inhibitor II Non-inhibitor 0.8771 Renal organic cation transporter Non-inhibitor 0.8042 CYP450 2C9 substrate Non-substrate 0.8358 CYP450 2D6 substrate Non-substrate 0.7949 CYP450 3A4 substrate Non-substrate 0.571 CYP450 1A2 substrate Inhibitor 0.8323 CYP450 2C9 inhibitor Inhibitor 0.6138 CYP450 2D6 inhibitor Non-inhibitor 0.5727 CYP450 2C19 inhibitor Non-inhibitor 0.8761 CYP450 3A4 inhibitor Non-inhibitor 0.6882 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.8829 Ames test Non AMES toxic 0.6384 Carcinogenicity Non-carcinogens 0.7073 Biodegradation Not ready biodegradable 1.0 Rat acute toxicity 2.6033 LD50, mol/kg  Not applicable hERG inhibition (predictor I) Weak inhibitor 0.7847 hERG inhibition (predictor II) Non-inhibitor 0.7439    ADMET data is predicted using  admetSAR , a free tool for evaluating chemical ADMET properties. ( 23092397 )  Spectra Mass Spec (NIST) Not Available Spectra Spectrum Spectrum Type Splash Key Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available Targets Build, predict & validate machine-learning models Use our structured and evidence-based datasets to  unlock newinsights and accelerate drug research. Learn more     Use our structured and evidence-based datasets to unlock new insights and accelerate drug research. Learn more Binding Properties × Property Measurement pH Temperature (°C) References IC 50 (nM) 40 7.5 30 A30565 
 
 
  Details 
 
 
   Binding Properties 1.  Cyclin-dependent kinase 2 Kind Protein Organism Humans Pharmacological action Unknown General Function Metal ion binding Specific Function Serine/threonine-protein kinase involved in the control of the cell cycle; essential for meiosis, but dispensable for mitosis. Phosphorylates CTNNB1, USP37, p53/TP53, NPM1, CDK7, RB1, BRCA2, MYC, N... Gene Name CDK2 Uniprot ID P24941 Uniprot Name Cyclin-dependent kinase 2 Molecular Weight 33929.215 Da References Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [ Article ]  
 
 
  Details 2.  Cyclin-A2 Kind Protein Organism Humans Pharmacological action Unknown General Function Not Available Specific Function Essential for the control of the cell cycle at the G1/S (start) and the G2/M (mitosis) transitions. Gene Name CCNA2 Uniprot ID P20248 Uniprot Name Cyclin-A2 Molecular Weight 48550.365 Da References Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [ Article ]  × Identify potential medication risks Easily compare up to 40 drugs with our drug interaction checker. Get severity rating, description, and management advice.  Learn more      Drug created at September 15, 2010 21:30 / Updated at June 12, 2020 16:52 